Jun. 18 at 8:05 AM
What the CMS 2027 QBP recalculation means for
$HUM and
$UNH
Notes, not advice. This is the flip side of the Clover discussion. The same June 17 CMS notice that operationalizes Clover’s court win also lifts the big incumbents, especially the ones who were fighting the call center measure. Worth laying out plainly.
Humana
Humana’s 2025 Star collapse was driven heavily by the call center measure (the foreign language interpreter and TTY test calls). A small number of failed test calls dragged down a dozen of its largest contracts and put a billion plus in bonus payments at risk. Humana sued CMS over it, lost, and is appealing. The June 17 recalc removes exactly that measure and only applies upgrades, holding downgrades harmless. So Humana looks like the single biggest beneficiary of this specific action: contracts hurt by the call center measure can see 2027 QBP upgrades that restore bonus eligibility, with the option to resubmit 2027 bids into richer benefits.
The honest caveat: this is 2027 QBP only. It does not undo the bonus damage already taken in 2025 and 2026, and it does not touch the 2027 Star Ratings that land in October. The appeal is also still open. But directionally, it is a real positive for Humana’s 2027 setup.
UnitedHealth
UNH benefits from the same mechanic, and as the largest MA player, even modest QBP upgrades across many contracts add up to large absolute dollars. But I would be honest about scale: for UNH this is a small tailwind against much bigger problems. UNH guided to a rare revenue decline in 2026, the first in a decade, is shedding members, faces a DOJ investigation into its Medicare participation and risk adjustment audit exposure, went through a CEO change, and the stock sits far below its highs. The recalc helps at the margin; it does not change that story. A footnote, not a fix.
The bigger picture
The through line is that this recalc raises the sector’s quality bonus pool rather than redistributing share. It is broadly positive for the big incumbents, Humana most directly, which is the same reason it is not the relative windfall for smaller players that some were hoping for. The bonus money is going up across the board, not moving from the giants to the challengers.
$CLOV got the original court win; the giants get to ride the same measure removal.
Not advice, just reading the read through.
